Patent details

92512 Product Name: Afoxolaner, ou un oxyde nitrique de celui-ci, ou un sel pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
92512
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP068482637
Legal Status:
Inactive
Application number:
92512
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/2/13/159
Marketing Authorization Type:
Marketing Authorization Date:
13/02/2014
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
05/08/2014
First Marketing Authorization date:
13/02/2014
Grant date:
06/10/2014
Activation date:
Publication date:
06/10/2014
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
13/02/2029
SPC Extension Expiration:
13/02/2029
Rejection date:
Withdrawal date:

Owner

From:
05/08/2014
 
 

Name:
E.I. DU PONT DE NEMOURS AND COMPANY
Address:
1007 Market Street, Wilmington, DE 19898, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
05/08/2014
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
XU Ming
Address:
United States (US)

2

Name:
LAHM George, Philip
Address:
United States (US)

3

Name:
SHOOP Wesley, Lawrence
Address:
United States (US)

Publication

Bulletin

Bulletin Heading:
SPC4
Bulletin edition number:
2023/12
Publication date:
06/11/2023
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

Annual Fees

Annual Fee Due Date:
31/12/2026
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56
02/10/2023 Publication 1
02/10/2023 Outgoing Correspondence 1
02/10/2023 Incoming Correspondence (Post) 1
02/10/2023 General Document 1